Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Moodys
Harvard Business School
Medtronic
Baxter

Last Updated: August 17, 2022

IMODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for IMODIUM
US Patents:0
Applicants:2
NDAs:8
Raw Ingredient (Bulk) Api Vendors: 41
Clinical Trials: 24
Patent Applications: 4,914
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in IMODIUM?IMODIUM excipients list
DailyMed Link:IMODIUM at DailyMed
Drug patent expirations by year for IMODIUM
Recent Clinical Trials for IMODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Naia PharmaceuticalsPhase 1/Phase 2
9 Meters Biopharma, Inc.Phase 1/Phase 2
McNeil ABPhase 1

See all IMODIUM clinical trials

US Patents and Regulatory Information for IMODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc IMODIUM loperamide hydrochloride CAPSULE;ORAL 017690-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM A-D EZ CHEWS loperamide hydrochloride TABLET, CHEWABLE;ORAL 020448-001 Jul 24, 1997 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride SOLUTION;ORAL 019487-001 Mar 1, 1988 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM MULTI-SYMPTOM RELIEF loperamide hydrochloride; simethicone TABLET, CHEWABLE;ORAL 020606-001 Jun 26, 1996 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM loperamide hydrochloride CAPSULE;ORAL 017694-001 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Janssen Pharms IMODIUM loperamide hydrochloride SOLUTION;ORAL 019037-001 Jul 31, 1984 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride TABLET;ORAL 019860-001 Nov 22, 1989 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for IMODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc IMODIUM loperamide hydrochloride CAPSULE;ORAL 017694-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Janssen Pharms IMODIUM loperamide hydrochloride SOLUTION;ORAL 019037-001 Jul 31, 1984 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for IMODIUM

See the table below for patents covering IMODIUM around the world.

Country Patent Number Title Estimated Expiration
Germany 2167193 See Plans and Pricing
Hong Kong 78076 2,2-DIARYL-4-(4-ARYL-4-HYDROXY-PIPERIDINO)-BUTYRAMIDES See Plans and Pricing
Germany 2126559 See Plans and Pricing
Japan S5936991 See Plans and Pricing
Hungary 166420 See Plans and Pricing
Austria 312606 See Plans and Pricing
U.S.S.R. 845776 METHOD OF PREPARING 2,2-DIARYL-4-(4'-OXYPIPERIDINO)-BUTYLAMIDES OR THEIR SALTS See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for IMODIUM

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0428296 SPC/GB98/013 United Kingdom See Plans and Pricing PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Baxter
AstraZeneca
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.